Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02270359 · ClinicalTrials.gov registry record · NA

Research on Infarction With Open Arteries Using OCT and CMR

A NA study of Myocardial Infarction, sponsored by NYU Langone Health.

Active
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT02270359: Active NA study of Myocardial Infarction, sponsored by NYU Langone Health.

NCT02270359 is a NA study of Myocardial Infarction that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 15 participants, below the 4,681-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02270359, a NA study of Myocardial Infarction, is active but no longer recruiting, sponsored by NYU Langone Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the prevalence of plaque disruption and to assess the composition of disrupted plaques in patients with myocardial infarction (MI) and non-obstructive coronary artery disease (CAD) using optical coherence tomography (OCT). Additionally, cardiac magnetic resonance imaging (CMR) will be used to detect myocardial abnormalities, which will be correlated to OCT findings to gain insight into the mechanisms of MI in patients with non-obstructive coronary artery disease (i.e. "open arteries").

Conditions Studied

Myocardial Infarction

Interventions

  • DEVICE OCT
  • PROCEDURE CMR
  • DRUG contrast agent, Gadolinium

Study Locations (1)

New York

  • NYU Langone Medical Center - New York

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2014-04
Est. Completion 2025-10-31
Phase NA
NYU Langone Health

1,164 total trials

What the registry record for NCT02270359 still lists

NCT02270359 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 4,681-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Myocardial Infarction appearing as the primary indexed condition, and to 3 interventions - of which OCT is the first listed.

NCT02270359 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02270359 about?

NCT02270359 is a clinical study titled "Research on Infarction With Open Arteries Using OCT and CMR". The purpose of this study is to determine the prevalence of plaque disruption and to assess the composition of disrupted plaques in patients with myocardial infarction (MI) and non-obstructive coronary artery disease (CAD) using optical coherence tomography (OCT). Additionally, cardiac magnetic reso...

What is the current status of trial NCT02270359?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2014-04. Estimated completion is 2025-10-31.

What conditions does trial NCT02270359 study?

This clinical trial studies the following conditions: Myocardial Infarction.

What interventions are being tested in trial NCT02270359?

The interventions under investigation include: OCT (DEVICE), CMR (PROCEDURE), contrast agent, Gadolinium (DRUG).

Who is sponsoring clinical trial NCT02270359?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02270359 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02270359's enrollment target sits among peer trials

15 63rd of 64 higher than 2 of 64 other Myocardial Infarction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT02270359, the US trial registry maintained by the National Library of Medicine. NCT02270359 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.